The effect of montelukast, a leukotriene receptor antagonist, on the acetic acid-induced model of colitis in rats: Involvement of NO-cGMP-KATP channels pathway
Inflammatory bowel disease is a chronic autoimmune disorder that may involve entire gastrointestinal tract. The leukotrienes have a role as mediators in the pathophysiology of colitis. Here, we investigated the effect of a leukotriene receptor antagonist, montelukast, and also the role of the NO-cGM...
Saved in:
Main Authors: | Behnam Ghorbanzadeh (Author), Mohammad Amin Behmanesh (Author), Roya Mahmoudinejad (Author), Mehdi Zamaniyan (Author), Shadi Ekhtiar (Author), Yousef Paridar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
by: James P Kemp
Published: (2009) -
Role of Leukotriene receptor antagonist Montelukast in the treatment of chronic urticaria: A hospital based study
by: Iffat Hassan, et al.
Published: (2012) -
The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review
by: Frank Pietrantonio, et al.
Published: (2024) -
Memory Enhancers for Alzheimer's Dementia: Focus on cGMP
by: Ernesto Fedele, et al.
Published: (2021) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013)